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Open access under the ElThe present study was conducted to evaluate the effect of 2-phenylethynyl-butyltellurium (PEBT), an
organotellurium compound, at doses of 5 and 10 mg/kg on memory, employing the step-down inhibitory
avoidance task in mice. Moreover, the involvement of glutamate uptake and release in cerebral cortex
and hippocampus of mice was investigated. A single oral administration (p.o.) of PEBT at the dose of
10 mg/kg 1 h before training (acquisition), immediately after training (consolidation) or 1 h before the
test session (retrieval) of the step-down inhibitory avoidance task increased the step-through latency
time in comparison to the control mice. In the open-ﬁeld test, no signiﬁcant differences in the number
of crossings and rearings were observed among groups. The [3H]glutamate uptake by cerebral cortex
and hippocampal slices of mice was signiﬁcantly inhibited after 1 h of treatment with PEBT. After 24 h
of PEBT exposure, only the hippocampal [3H]glutamate uptake was inhibited. The [3H]glutamate release
by cerebral cortex and hippocampal synaptosomes of mice was not altered. These results suggest that
PEBT improved memory stages (acquisition, consolidation and retrieval) in the step-down inhibitory
avoidance task in mice. The improvement of memory by PEBT seems most likely to be mediated through
an interaction with the amino acid transporters of the glutamatergic system.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
The biological effects of inorganic and organic tellurium
compounds have been studied, leading to a set of interesting and
promising applications (Cunha et al., 2009). For instance, pre-
administration of an organotellurane avoided the establishment of
the status epilepticus in rats (Persike et al., 2008). Besides, tellurides
are promising antitumoral drugs and their chemoprotective effects
can be related to their cytotoxic properties and to their ability to in-
hibit important enzymes necessary for the tumor growth (Engman
et al., 2000; Cunha et al., 2005). Additionally, Ávila et al. (2010)
demonstrated the neuroprotective activity of a vinylic telluride
compound against Mn-induced neurotoxicity.
Organotellurium compounds have been also reported as antiox-
idants in several models of oxidative stress (Briviba et al., 1998;
Jacob et al., 2000), especially in brain (Ávila et al., 2008). Recently,
our research group showed the antioxidant effect of telluroacetyl-
enes on rat brain homogenate in vitro (Souza et al., 2009). Moreover,
2-phenyletinil-butyltellurium (PEBT) (Fig. 1), a telluroacetylene
compound, protected against oxidative damage caused by sodium
nitroprusside in mouse brain, suggesting an antioxidant effect
in vivo of this compound (Souza et al., 2009).x: +55 55 3220 8978.
gueira).
sevier OA license.Glutamate has a pivotal role in neuroplasticity, learning and
memory processes (Flood et al., 1990; Izquierdo and Medina,
1997; Castellano et al., 2001; Whitlock et al., 2006). The central
nervous system strictly regulates the ﬁne balance between gluta-
mate release and uptake. When glutamate is released in the synap-
tic cleft, it is uptaked by speciﬁc high afﬁnity Na+-dependent amino
acid transporters, which are mainly present in glial cells, and
metabolized by the glutamine pathway, transported as glutamine
to the neurons and stored as glutamate now in the vesicles of
pre-synaptic neuron to be released again (Fykse and Fonnum,
1996; Danbolt, 2001; Sheldon and Robinson, 2007). In that way,
facilitated glutamate transmission leads to consequent increase
in learning (Lhullier et al., 2004; Mameli et al., 2005).
In view of the pharmacological properties of organotellurium
compounds, the present study evaluated the effect of PEBT on
the three stages of memory, acquisition, consolidation and retrie-
val, employing the step-down inhibitory avoidance task in mice.
Moreover, the involvement of glutamate uptake and release in
the improvement of memory caused by PEBT were investigated.
2. Materials and methods
2.1. Chemicals
PEBTwas prepared according to the literaturemethod (Comasseto
et al., 1996). Analysis of the 1HNMR and 13CNMR spectra showed
Te
Fig. 1. Chemical structure of 2-phenylethynyl-butyltellurium (PEBT).
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in full agreementwith its assigned structure. PEBTwas diluted in ca-
nola oil. L-[3H]glutamate (speciﬁc activity 30 Ci/mmol) was pur-
chased from Amersham International, UK. All other chemicals
were obtained of the analytical grade and from standard commer-
cial suppliers.
2.2. Animals
The experiments were conducted using male adult Swiss mice
(25–35 g) from our own breeding colony. Animals were main-
tained at 22 ± 2 C with free access to water and food (Guabi, RS,
Brazil), under a 12:12 h light/dark cycle (with lights on at
7:00 a.m.). Mice were acclimatized to the laboratory for at least
1 h before testing. Animals were used according to the guidelines
of the Committee on Care and Use of Experimental Animal
Resources, the Federal University of Santa Maria, Brazil.
2.3. Behavioral tasks
2.3.1. Step-down inhibitory avoidance
Non-spatial long-term memory was investigated using a step-
down inhibitory avoidance task according to themethod of Sakaguchi
et al. (2006), with some modiﬁcations. Each mouse was placed on
the platform, and the latency to step-down (four paws on the grid)
was automatically recorded in training and test sessions. In the
training session, upon stepping down, the mouse received a
0.5 mA scrambled foot shock for 2 s. Test sessions were performed
24 h later, with the same procedure except that no shock was
administered after stepping down; an upper cutoff time of 300 s
was set. Six to eight animals were used per group. PEBT at the doses
of 5 or 10 mg/kg orally (p.o.) (Souza et al., 2009), or vehicle (canola
oil 10 ml/kg, p.o.) were given 1 h before training (acquisition),
immediately post-training (consolidation), or 1 h before test (retrie-
val). The oral route dominates contemporary drug therapy and is
considered to be safe, efﬁcient and easily accessible with minimal
discomfort compared to other routes of administration (Lennernãs,
2007).
2.3.2. Open-ﬁeld
Spontaneous locomotor activity was measured in the open-ﬁeld
test (Walsh and Cummins, 1976). The open-ﬁeld was made of ply-
wood and surrounded by walls 30 cm in height. The ﬂoor of the
open-ﬁeld, 45 cm in length and 45 cm in width, was divided by
masking tape markers into 9 squares (3 rows of 3). Each animal
was placed individually at the center of the apparatus and ob-
served for 4 min to record the locomotor (number of segments
crossed with the four paws) and exploratory activities (expressed
by the number of time rearing on the hind limbs). Six to eight
animals were used per group. The locomotor and exploratory
activities were evaluated after the test session of the step-down
inhibitory avoidance task.
2.4. Ex vivo assay
In order to investigate the possible mechanisms involved in the
effect of PEBT on memory, glutamate uptake and release assays
were carried out 1 h (training) or 24 h (test of memory) after oral
administration of PEBT (10 mg/kg).2.4.1. [3H] Glutamate uptake
Glutamate uptake was performed according to Thomazi et al.
(2004). One and 24 h after oral administration of PEBT, mice were
killed by cervical dislocation and the brains were immediately re-
moved. Slices (0.4 mm) were obtained by transversally cuts of cor-
tex and hippocampus using a McIlwain chopper. Experiments were
made in triplicates. Slices were pre-incubated for 15 min at 37 C
in a Hank’s balanced salt solution (HBSS) containing (in mM):
137 NaCl, 0.63 Na2HPO4, 4.17 NaHCO3, 5.36 KCl, 0.44 KH2PO4,
1.26 CaCl2, 0.41 MgSO4, 0.49 MgCl2 and 1.11 glucose, adjusted to
pH 7.2. Then, 0.66 and 0.33 lCi ml1 L-[3H]glutamate for hippo-
campus and cortex, respectively, in a 100 lM ﬁnal concentration
of glutamate were added. Incubation was stopped after 5 or
7 min for hippocampus and cortex, respectively, with three ice-
cold washes of 1 ml HBSS, immediately followed by the addition
of 0.5 N NaOH, which was then kept overnight. An aliquot of
10 ll was removed to protein determination. Unspeciﬁc uptake
was measured using the same protocol described above, with dif-
ferences in the temperature (4 C) and medium composition (cho-
line chloride instead of sodium chloride). Na+-dependent uptake
was considered as the difference between the total uptake and
the unspeciﬁc uptake. Incorporated radioactivity was measured
using a liquid scintillation counter (Wallac 1409). Results were ex-
pressed as pmol [3H]glutamate uptake/mg protein min1.
2.4.2. Synaptosomal preparation
Synaptosomal preparations were obtained by isotonic Percoll/
sucrose discontinuous gradients at 4 C, as previously described
(Dunkley et al., 1986) with fewmodiﬁcations. Brieﬂy, homogenates
(10%, w/v) from cortex and hippocampus were made in 0.32 M su-
crose, 1 mM ethylenediaminetetraacetic acid (EDTA) and 6.25 mM
dithiotreitol (DDT) (pH 7.4), and centrifuged at 800g for 10 min.
The supernatants containing synaptosomes were subjected to
23%, 15%, 7% and 3% Percoll solution density gradient centrifuga-
tion at 24,000g for 10 min. The synaptosomal fractions were iso-
lated, suspended and homogenized in buffered HBSS containing
low K+ (pH 7.4), containing in mM: 133 NaCl, 2.4 KCl, 1.2 KH2PO4,
1.09 MgSO4, 27.7 HEPES, 1.2 glucose and 0.001 CaCl2 and centri-
fuged at 21,000g for 15 min. The supernatant was removed and
the pellet gently resuspended in HBSS buffer.
2.4.3. Synaptosomal [3H] glutamate release
Determination of [3H]glutamate release was accomplished as
described by Migues et al. (1999). Prior to the release assay, syn-
aptosomal preparations from cortex and hippocampus of mice
were loaded with labeled [3H]glutamate for 15 min at 37 C. Incu-
bation was performed in a non-depolarizing medium (low potas-
sium), containing, in mM: HEPES 27, NaCl 133, KCl 2.4, MgSO4
1.2, KH2PO4 1.2, glucose 12, CaCl2 1.0 in the presence of 0.5 lM
of glutamate (0.1 lCi [3H]glutamate). Aliquots of labeled synapto-
somal preparations were centrifuged at 16,000g for 1 min. Super-
natants were discarded and the pellets were washed four times in
the medium by centrifugation at 16,000g for 1 min (at 4 C). To
assess the basal release of [3H]glutamate, the ﬁnal pellet was
resuspended in the same buffer and incubated for 1 min at
37 C. Incubation was terminated by immediate centrifugation
(16,000g for 1 min). Radioactivity present in supernatants and
pellets was separately determined. The [3H]glutamate release
was calculated as the percentage of total amount of radiolabel
glutamate present at the start of the incubation period in preload-
ed synaptosomes.
2.4.4. Protein determination
Protein concentration was measured according to Bradford
(1976), using bovine serum albumin (1 mg/ml) as the standard.
A.C.G. Souza et al. / Neurochemistry International 60 (2012) 409–414 4112.5. Statistical analysis
Step-through latencies are expressed as median and interquar-
tile range, since these data demonstrated a non parametric distri-
bution. Statistical analysis of step-down inhibitory avoidance
task was carried out by Kruskal–Wallis test. All other results are
presented as means ± S.E.M. The statistical signiﬁcant difference
between groups of the open-ﬁeld test was calculated by means
of one-way analysis of variance (ANOVA) followed by Duncan’s test
when appropriate. Statistical analysis of glutamate uptake and re-
lease was carried out by Student’s t-test. P values less than 0.05
(P < 0.05) were considered as indicative of signiﬁcance.3. Results
3.1. Behavioral tasks
3.1.1. Effect of PEBT on the step-down inhibitory avoidance task
Fig. 2 shows the effect of PEBT on the step-down inhibitory
avoidance task in mice. During the training session in the step-
down inhibitory avoidance task, there was no difference in the
step-through latency time among groups. Oral administration of
PEBT, at the dose of 10 mg/kg, 1 h before the training (acquisition)
(Fig. 2a) and immediately after the training session (consolidation)
(Fig. 2b) to mice increased the step-through latency in comparison
to the control group. The dose of 10 mg/kg of PEBT administrated
1 h before the test session (retrieval) increased the step-through
latency time in comparison to the control group (Fig. 2c). The low-
est dose of PEBT (5 mg/kg) did not alter the step-through latency
time in the three stages of memory (Fig. 2a–c).3.1.2. Effect of PEBT on the open-ﬁeld test
Locomotor and exploratory activities evaluated after the test
session of the step-down inhibitory avoidance task are shown in
Fig. 3. Administration of PEBT at both doses pre-training (Fig. 3a),
immediately post-training (Fig. 3b) and before test (Fig. 3c) did
not alter the number of crossings and rearings in the open-ﬁeld
test in mice.Fig. 2. Effect of PEBT on the step-down inhibitory avoidance task in mice. PEBT at
the dose of 5 or 10 mg/kg was administered, p.o., 1 h before training session
(acquisition) (a), immediately post-training (consolidation) (b) and 1 h before test
(retrieval) (c). Each column represents median with interquartile range from 6 to 83.2. Ex vivo assay
3.2.1. Effect of PEBT on the [3H]glutamate uptake
Fig. 4 shows the effect of PEBT (10 mg/kg, p.o.) on the [3H]glu-
tamate uptake by cerebral cortex and hippocampal slices of mice.
One hour after PEBT administration, the [3H]glutamate uptake in
cerebral cortex and hippocampus was signiﬁcantly inhibited
around of 61% and 37%, respectively (Fig. 4a and b, respectively).
After 24 h of PEBT administration, the hippocampal [3H]glutamate
uptake remained signiﬁcantly inhibited around of 51% (Fig. 4d).
The effect of PEBT on cerebral cortex [3H]glutamate uptake disap-
peared after 24 h administration (Fig. 4c).animals per group. Data were analyzed by Kruskal–Wallis test. () P<0.05 when
compared to the control group. Abbreviation: Te – PEBT.3.2.2. Effect of PEBT on the [3H]glutamate release
Fig. 5 shows the effect of PEBT (10 mg/kg, p.o.) on the [3H]glu-
tamate release by cerebral cortex and hippocampal synaptosomes
of mice. At 1 and 24 h after PEBT administration, the [3H]glutamate
release was not altered in comparison to the control group.
4. Discussion
In this study, we demonstrated that PEBT, a telluroacetylene
compound, induced memory improvement when administered to
mice before training (effect on memory acquisition), immediately
after training (effect on memory consolidation) and before test (ef-fect on memory retrieval) of step-down inhibitory avoidance task.
Moreover, the inhibition of [3H]glutamate uptake was proven to be
involved in the PEBT improvement of memory.
Memory is often considered to be a process that has several
stages, including acquisition, consolidation and retrieval (Abel
and Lattal, 2001). Memory acquisition occurs as the animal learns
an association between a context and a shock. During consolida-
tion, which can last from minutes to hours, this memory is moved
from a labile to a more ﬁxed state. During retrieval, the animal is
returned to the conditioning context, where memory for the con-
text-shock association is assessed (Abel and Lattal, 2001).
Fig. 3. Effect of PEBT on the open-ﬁeld test in mice. Locomotor and exploratory
activities were evaluated after the test session of the step-down inhibitory
avoidance task. Administration of PEBT at doses of 5 and 10 mg/kg (p.o.) pre-
training (a), post-training (b) and pre-test (c). Each column represents mean ± -
S.E.M. from 6 to 8 animals per group. Statistical analysis was performed by one-way
ANOVA followed by Duncan’s test when appropriate. Abbreviation: Te – PEBT.
Fig. 4. Effect of PEBT on the [3H]glutamate uptake by cerebral cortex and
hippocampal slices of mice. Cerebral cortex (a) and hippocampal (b) [3H]glutamate
uptake 1 h after administration of PEBT at the dose of 10 mg/kg (p.o.). Cerebral cortex
(c) and hippocampal (d) [3H]glutamate uptake 24 h after administration of PEBT at
the dose of 10 mg/kg (p.o.). Each column represents mean ± S.E.M. from experiments
performed in triplicates. Statistical analysis was performed by Student’s t-test. ()
P < 0.05 when compared to the control group. Abbreviation: Te – PEBT.
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administration of PEBT (10 mg/kg, p.o.), 1 h before training of
step-down inhibitory avoidance task, increased the step-through
latency. In other words, PEBT improved the acquisition of memory
in mice. Furthermore, the effect of post-training administration of
PEBT on the consolidation process was evaluated. In memory stud-
ies, where drugs are administered after, not before training, the
drug’s effects can be attributed to inﬂuences in the consolidation
of memory, a process which takes place immediately after the
training experience and lasts for few hours [for a review see
(McGaugh, 1989; Castellano et al., 2001)]. PEBT (10 mg/kg, p.o.)
administered immediately after training enhanced memory con-
solidation due to the increase in the step-through latency. Pre-test
administration of drugs may affect retrieval process which implies
the reactivation of memories and variety of factors can modify re-
trieval at the time of testing (McGaugh, 2000). In the present study,
pre-test administration of PEBT (10 mg/kg, p.o.) improved retrieval
of memory in the step-down inhibitory avoidance task. By contrast,
5 mg/kg dose of PEBT did not improve acquisition, consolidation orretrieval. Moreover, it is important to mention that PEBT did not
cause impairment in the locomotor activity and exploratory
behavior of mice assessed by the open-ﬁeld test.
Fig. 5. Effect of PEBT on the [3H]glutamate release by cerebral cortex and
hippocampal synaptosomes of mice. Cerebral cortex and hippocampal synapto-
somes (a) [3H]glutamate release 1 h after administration of PEBT at the dose of
10 mg/kg (p.o.). Cerebral cortex and hippocampal synaptosomes (b) [3H]glutamate
release 24 h after administration of PEBT at the dose of 10 mg/kg (p.o.). Each
column represents mean ± S.E.M. from experiments performed in triplicates.
Statistical analysis was performed by Student’s t-test. Abbreviation: Te – PEBT.
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considering the facilitatory effect of the glutamatergic system on
the memory of various tasks, we investigated the possible involve-
ment of glutamatergic neurotransmission in the PEBT action. The
amino acid glutamate, the main excitatory neurotransmitter in the
mammalian brain, is known to play important roles in several phys-
iological processes, such as cognition and neural plasticity of synap-
tic connections (Meldrum, 2000; Mattson, 2008). Our results
demonstrated that PEBT at the dose of 10 mg/kg inhibited [3H]glu-
tamate uptake, but not [3H]glutamate release, in cerebral cortex
and hippocampus of mice. Accordingly, diphenyl diselenide and
diphenyl ditelluride, organochalcogen compounds, did not alter
[3H]glutamate release by rat brain synaptosomes in vivo (Nogueira
et al., 2002). Therefore, the [3H]glutamate uptake seems to be re-
lated, at least in part, to themechanismsbywhichPEBT induces cog-
nitive enhancement in the step-down inhibitory avoidance task in
mice. These ﬁndings are consistent with those reported by different
research groups (Daisley et al., 1998; Lhullier et al., 2004; Mameli
et al., 2005), in which facilitated glutamate transmission with con-
sequent increase in learning has been demonstrated. It is important
to point out that an excessive increase of glutamate concentration in
the synaptic cleftmayproduce neurotoxic effects associatedwith an
over stimulation of the glutamatergic system, a process known as
excitotoxicity, leading to cell death. An unbalanced increase or
decrease in the glutamatergic system is highly neurotoxic. In fact,
a ﬁne tuning of glutamatergic system functioning is essential for
proper brain functioning (Ozawa et al., 1998; Mattson, 2008).
Similar to PEBT, diphenyl diselenide and diphenyl ditelluride
are able to inhibit [3H]glutamate uptake (Souza et al., 2010). Thesecompounds oxidize sulfhydryl groups of glutamate transporter
proteins, disrupting the glutamatergic system (Moretto et al.,
2007). The redox modulation of glutamate transporter proteins
has been demonstrated by using agents that oxidize thiol groups,
such as 5,50-dithio-bis-(2-nitrobenzoic) acid (DTNB) and dithiol
chelating agents. In fact, DTNB and dithiol chelating agents inhibit
the glutamate uptake (Trotti et al., 1996, 1997; Nogueira et al.,
2001). Moreover, ebselen, another organochalcogen compound,
selectively modulates the redox site of the NMDA receptor by oxi-
dizing thiol groups of the receptor in vitro (Herin et al., 2001) and
the peripheral glutamatergic system (Meotti et al., 2009).
Studies of our research group demonstrated that PEBT inhibited
in vitro d-aminolevulinate dehydratase (ALA-D) activity, a sulfhy-
dryl-containing enzyme, in rat brain homogenate. In this study,
dithiothreitol restored d-ALA-D activity (Souza et al., 2009). Since
the mechanism involved in d-ALA-D inhibition caused by PEBT is
related to their ability to oxidize sulfhydryl groups, it is possible
that PEBT inhibits [3H]glutamate uptake by oxidation of SH–
groups of glutamate transporter proteins. The speciﬁc high afﬁnity
Na+-dependent amino acid transporters contain reactive –SH
groups in their structure that are modulated by their redox status
(Trotti et al., 1999). From these results it is possible to hypothesize
that PEBT alters the redox modulation of reactive amino acids in
glutamate transporter proteins. It is important to highlight that
the oxidation of sulfhydryl groups of glutamate transporter pro-
teins was spontaneously recovered since cerebral cortex [3H]gluta-
mate uptake inhibition disappeared after 24 h of administration.5. Conclusion
In conclusion, the present study established, for the ﬁrst time,
that PEBT administration to mice caused cognitive enhancement
in the three evaluated memory phases (acquisition, consolidation
and retrieval) in the step-down inhibitory avoidance task. Based
upon data from the literature pointing to a modulatory effect of
glutamate on behavioral performances, results presented here
could indicate that by decreasing glutamate uptake, PEBT could
strengthen the physiological glutamatergic tonus, consequently
improving memory on the step-down inhibitory avoidance task.
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